Nuclear Medicine: Innovation in Cancer Detection and Treatment

Nuclear medicine is a branch of medicine that focuses on using radioactive substances for the diagnosis and treatment of diseases, especially cancer. The Nuclear Medicine Unit at Chularat Hospital's Cheewarak Cancer Center utilizes advanced technology, such as SPECT/CT scans, to provide highly accurate diagnostic services. This ensures patients receive appropriate care from the earliest stages of treatment.

Role of the Nuclear Medicine Unit

The Nuclear Medicine Unit plays a crucial role in diagnosing cancer and other related diseases. It uses SPECT/CT technology, which combines radiological imaging with CT scans. This allows doctors to view both the functional activity of organs and their physical structures simultaneously. As a result, diagnoses are highly accurate, and it can detect abnormalities that might be missed by conventional methods.

How SPECT/CT Works

• SPECT/CT Imaging: A Combined Approach to Diagnosis SPECT/CT (Single Photon Emission Computed Tomography/Computed Tomography) is a powerful tool that merges two distinct technologies. This combination provides both functional images of organ activity and detailed images of anatomical structures simultaneously. In cancer diagnosis, using SPECT/CT allows physicians to precisely pinpoint abnormalities, enabling them to tailor treatment plans to each patient's specific condition.
• Comprehensive Diagnostic Capabilities Beyond cancer diagnosis, SPECT/CT is also utilized for examining various other conditions, including cardiovascular diseases, neurological disorders, and thyroid-related illnesses. This technology significantly broadens the scope and accuracy of diagnostic assessments.

Nuclear Medicine Treatment

Nuclear medicine plays a vital role not only in diagnosis but also in cancer treatment through Radionuclide Therapy. This method uses radioactive substances that directly destroy cancer cells, such as Iodine-131 for thyroid cancer and Lutetium-177 (Lu-177) for prostate cancer.

• Iodine-131 Treatment: Targeting Thyroid Cancer Iodine-131 (I-131) is a specific type of radionuclide therapy primarily used for thyroid cancer. Its effectiveness stems from the unique ability of thyroid cells (both normal and cancerous) to absorb iodine from the bloodstream to produce thyroid hormones. When a patient receives Iodine-131 (usually as a capsule or liquid), it travels through the bloodstream and is selectively taken up and concentrated by thyroid cells, including any remaining cancerous thyroid cells. Once inside these cells, I-131 emits beta particles, which are high-energy electrons with a short range of penetration. This localized radiation effectively damages the DNA of the cancer cells, leading to their destruction, while minimizing harm to surrounding healthy tissues that do not absorb iodine. Iodine-131 therapy is often used after surgery to destroy any remaining thyroid tissue or cancerous cells, including those that may have spread to other parts of the body (metastases) if those metastatic cells also retain the ability to absorb iodine.
• Lutetium-177 Treatment: Precision for Prostate Cancer Lutetium-177 (Lu-177) is another significant radionuclide used in targeted cancer therapy, particularly for advanced prostate cancer. Unlike Iodine-131, which relies on a natural uptake mechanism, Lu-177 is typically attached to a targeting molecule called PSMA (Prostate-Specific Membrane Antigen). PSMA is a protein that is often found in high concentrations on the surface of prostate cancer cells, including those that have spread. When Lu-177-PSMA is administered, the PSMA component acts like a "homing device," specifically seeking out and binding to the prostate cancer cells. Once attached, the Lu-177 emits beta particles (similar to I-131) that directly deliver a localized dose of radiation to the cancer cells. This targeted radiation damages the cancer cells' DNA, leading to their death and shrinking the tumor. The advantage of Lu-177 PSMA therapy is its precision. By specifically targeting PSMA-expressing cancer cells, it aims to maximize the radiation dose to the tumor while minimizing exposure and potential side effects to healthy surrounding tissues, leading to improved patient outcomes and quality of life. This makes it a valuable option for patients with metastatic prostate cancer, especially those who have not responded to other treatments.

Benefits of Nuclear Medicine in Cancer Treatment

1. Early Cancer Detection With SPECT/CT technology, cancer can be detected in its early stages. This is a crucial factor that significantly increases the chances of successful treatment and recovery.
2. Treatment Precision The use of targeted radioactive substances allows for the precise destruction of cancer cells without harming normal tissues.
3. Treatment Plan Adjustment Physicians can accurately monitor the response to treatment, enabling them to adjust the treatment plan according to the patient's condition.
4. Symptom Relief Beyond treating cancer, nuclear medicine can also be used to alleviate symptoms for patients whose condition cannot be cured. For example, it can reduce the size of a cancerous mass to improve the patient's quality of life.

Safety Standards in Nuclear Medicine Usage

The Nuclear Medicine Unit at Chularat Hospital places the highest importance on safety standards, encompassing both radiation dose control and patient safety care. Strict monitoring and control measures are implemented to ensure that patients receive the safest possible treatment.

Expert Medical Team and Staff

The medical team and staff at the Nuclear Medicine Unit undergo continuous training and development. This ensures they can effectively utilize modern medical technology to diagnose and treat patients.

With its advanced technology and expertise, the Nuclear Medicine Unit at Chularat Hospital's Cancer Center is a leading facility providing highly effective and precise cancer treatments. This commitment ensures that cancer patients receive the best and most up-to-date care available.